Leerink: Translate Bio's Cystic Fibrosis Candidate Could Generate

S-1

EX-99.1

C&EN's Year in Pharma 2019

With $3.2B, Sanofi takes in mRNA partner Translate Bio in buyout deal

EX-99.1

Genes, Free Full-Text

Frontiers Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine

SEC Filing Arcturus Therapeutics, Inc.

SEC Filing Arcturus Therapeutics, Inc.